EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single‐Centre Clinical Series

Berkan Acar iD, Ali Muhtaroğlu iD, Murat Akalin iD, Elif Yilmaz iD, Mehmet Yildiz iD

International Wound Journal · 2026-05 · 23 (5)

DOI: 10.1111/iwj.70942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Wound Journal, online erschienen am 21.05.2026. Verfasst von Berkan Acar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Giresun University, Faculty of Medicine, Giresun, Turkey. Hauptthemen laut MEDLINE: Pilonidal Sinus, Phenol, Sclerosing Solutions, Sclerotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate short‐term treatment outcomes and treatment burden in patients with presacral pilonidal sinus disease managed with crystallised phenol in a single‐centre clinical series, with particular emphasis on the relationship between pit burden and session requirement.

Methods

Consecutive patients treated with crystallised phenol were analysed ( n = 40). Demographic and clinical characteristics, symptom duration, pit count, number of phenol sessions (2 vs. 3), inter‐session intervals, and total treatment duration were recorded. All patients completed scheduled clinical reassessment at 5 weeks and 3 months. Treatment‐related abscess and recurrence during follow‐up were documented. Continuous variables are presented as mean ± standard deviation and median (minimum–maximum). Comparisons between the two‐session and three‐session groups were performed with the Mann–Whitney U test for continuous variables and Fisher's exact test for categorical variables.

Results

The cohort was predominantly male (75%), with a mean age of 29.23 ± 9.85 years and a mean body mass index of 25.81 ± 3.85 kg/m 2 ; 62.5% were smokers. Symptom duration was 6.80 ± 7.20 months, and mean pit count was 1.90 ± 0.93. Two sessions were sufficient in 42.5% (17/40), whereas 57.5% (23/40) required three sessions. The interval between the first and second sessions was 11.32 ± 3.30 days, and the interval between the second and third sessions was 11.96 ± 3.23 days in patients who underwent three sessions; overall treatment duration was 18.2 ± 7.58 days. No patient was lost to follow‐up. Pit burden was the strongest determinant of requiring a third session: pit count was significantly higher in the three‐session group than in the two‐session group (2.39 ± 0.89 vs. 1.24 ± 0.44, p < 0.001), and all patients with ≥ 3 pits required three sessions. Smoking status ( p = 1.000) and body mass index (BMI) ( p = 0.208) were not associated with session requirement. Treatment‐related abscess developed in 12.5% (5/40), and recurrence during the 3‐month follow‐up was observed in 12.5% (5/40); notably, all such events occurred in the three‐session group (0/17 vs. 5/23, p = 0.061 for both comparisons).

Conclusion

In this single‐centre series, crystallised phenol provided acceptable short‐term outcomes and a relatively short treatment course in presacral pilonidal sinus disease. Pit count emerged as the main determinant of requiring a third session, whereas smoking status and BMI were not associated with session requirement. Larger studies with longer follow‐up are needed to clarify predictors of recurrence and to determine whether higher session requirements simply reflect disease complexity or also influence outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pilonidal SinusPhenolSclerosing SolutionsSclerotherapyHumansMaleFemaleAdultTreatment OutcomeYoung AdultSacrococcygeal Region

Stichwörter der Autor:innen

crystallised phenolpilonidal sinus diseasepit countpresacralrecurrence

Substanzen

PhenolSclerosing Solutions

Autor:innen und Institutionen

  • Department of General Surgery, Giresun University, Faculty of Medicine, Giresun, Turkey.
  • Department of General Surgery, İzmir Bakırçay University Çiğli Training and Research Hospital, İzmir, Turkey.
  • General Surgery Clinic, Private Umut Hospital, Ordu, Turkey.
  • Giresun Provincial Directorate, Bulancak Family Health Centre, Ordu, Turkey.

ORCID-Profile: Berkan Acar, Ali Muhtaroğlu, Murat Akalin, Elif Yilmaz, Mehmet Yildiz

Zitieren

APA

Acar, B., Muhtaroğlu, A., Akalin, M., Yilmaz, E., & Yildiz, M. (2026). Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single‐Centre Clinical Series. International Wound Journal, 23(5). https://doi.org/10.1111/iwj.70942

Vancouver

Acar B, Muhtaroğlu A, Akalin M, Yilmaz E, Yildiz M. Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single‐Centre Clinical Series. International Wound Journal. 2026;23(5). doi:10.1111/iwj.70942

BibTeX
@article{Acar2026,
  author = {Acar, Berkan and Muhtaroğlu, Ali and Akalin, Murat and Yilmaz, Elif and Yildiz, Mehmet},
  title = {Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single‐Centre Clinical Series},
  journal = {International Wound Journal},
  year = {2026},
  volume = {23},
  number = {5},
  doi = {10.1111/iwj.70942}
}
Kostenlos starten →